Intellectual property protection: strategies for antibody inventions (Q39760405)

14 September 2017

Intellectual property protection: strategies for antibody inventions (English)

1 reference

14 September 2017

intellectual property

0 references

author name string

Ulrich Storz

series ordinal

1

1 reference

14 September 2017

1 May 2011

1 reference

14 September 2017

Monoclonal Antibodies

1 reference

14 September 2017

3

1 reference

14 September 2017

3

1 reference

14 September 2017

310-317

1 reference

Engineered protein scaffolds as next-generation antibody therapeutics.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3149711

How many drug targets are there?

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3149711

Continuous cultures of fused cells secreting antibody of predefined specificity

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3149711

Guardians at the gate: patent protection for therapeutic monoclonal antibodies--part 1.

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3149711

Predictors of competing mortality in advanced head and neck cancer

11 August 2018

1 reference

Crossref

https://api.crossref.org/works/10.4161%2FMABS.3.3.15530

Toward biosimilar monoclonal antibodies

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21494091

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.4161/MABS.3.3.15530

1 reference

14 September 2017

1 reference

14 September 2017

1 reference

PMCID

3149711